HomeNRX • CVE
add
Nurexone Biologic Inc
Previous close
$0.70
Day range
$0.69 - $0.70
Year range
$0.19 - $1.19
Market cap
47.00M CAD
Avg Volume
99.54K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 695.00K | 101.45% |
Net income | -922.00K | -30.78% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -905.00K | -26.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.26M | 104.97% |
Total assets | 4.14M | 102.64% |
Total liabilities | 511.00K | -21.38% |
Total equity | 3.63M | — |
Shares outstanding | 67.11M | — |
Price to book | 11.67 | — |
Return on assets | -72.88% | — |
Return on capital | -91.22% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -922.00K | -30.78% |
Cash from operations | -1.46M | -78.01% |
Cash from investing | -241.00K | -363.46% |
Cash from financing | 4.40M | 55,075.00% |
Net change in cash | 2.71M | 410.17% |
Free cash flow | -114.00K | 81.05% |
About
Founded
2011
Website
Employees
12